Why a Peptide Can Change While It Sits in the Vial

Why a Peptide Can Change While It Sits in the Vial

A lyophilized peptide looks frozen in time. A dry powder, sealed under a cap, holding still. The easy assumption is that what went into the vial is what comes out six months later.

The chemistry disagrees. Even in a cold, dry, sealed vial, some peptides are slowly turning into slightly different molecules.

The most common reason rarely shows up on a certificate of analysis. It is called deamidation, and it is the single most common chemical degradation pathway for peptides and proteins. It does not care that the sample passed its purity test.

The reaction that keeps running

Deamidation is spontaneous and nonenzymatic. It targets an asparagine residue, stripping away the side-chain amide group and turning a neutral asparagine into a negatively charged aspartic acid, or more often into its isomer, isoaspartate.

The reaction passes through a five-membered succinimide ring. In neutral or slightly alkaline solution, the backbone nitrogen of the next amino acid attacks the asparagine side chain, closes the ring, and releases ammonia. The ring then opens one of two ways, yielding either the normal aspartate or the kinked isoaspartate, in roughly a one-to-three ratio.

The product has the same chain length, nearly the same mass, and a different structure. It is no longer exactly the molecule on the label.

It depends on the sequence, not the supplier

What makes deamidation useful to understand is how sharply it depends on the peptide's own sequence.

In 1987, Geiger and Clarke measured the reaction in a model peptide and found that the sequence Val-Tyr-Pro-Asn-Gly-Ala deamidates with a half-life of about 1.4 days at 37 degrees Celsius. Swap the glycine for a bulkier residue and the reaction slows by more than 30-fold.

The identity of the residue right after the asparagine, the n+1 position, dominates the rate. An Asn-Gly pair deamidates far faster than an Asn-Ile or Asn-Val pair, because glycine is small and flexible and offers little resistance to the ring closing. A proline in that spot blocks the reaction almost entirely, since its nitrogen cannot deprotonate the way the mechanism requires.

Robinson and Robinson later turned this into a quantitative, sequence-based prediction of deamidation rates from primary structure alone. The practical point is that two peptides with identical purity can have very different long-term stability, purely because of how their sequence is written.

Oxidation is the other slow editor

Deamidation is not the only reaction running in a sealed vial. Oxidation edits a different set of residues.

Methionine and cysteine are the usual targets, because their sulfur atoms are reactive. Methionine picks up one oxygen to form methionine sulfoxide, and under harsher conditions a second oxygen to form methionine sulfone, a change that is hard to reverse. Cysteine can oxidize into disulfide links or further into sulfinic and sulfonic acids.

Warmth, moisture, oxygen, and light all speed these reactions up. A storage note about keeping material cold, dry, and sealed is not fine print. It is a recorded method for slowing reactions that run on their own.

Why the purity number usually does not move

Here is the part that matters when you read a certificate.

A typical purity figure is an HPLC area-percent, the fraction of UV-detected peak area that belongs to the main component at one moment in time. A deamidated or oxidized variant can be extremely close to the parent, sometimes differing by a single oxygen atom or a rearranged side chain.

So a sample can accumulate degradation products and drift in identity while printing nearly the same purity number. The certificate describes the material when it was tested, not the material in your hands months later.

Identity, purity, and stability are three different questions. A purity test answers the second, at a single time point. It does not promise the first holds forever, and it does not measure the third at all.

What to ask for instead

When you need a peptide to behave like the reference it was compared against, look past the headline purity and ask narrower questions.

Is there a stated storage condition and a testing date? Does the documentation mention deamidation, oxidation, or aggregation, or only chemical purity? Where the sequence carries an Asn-Gly, Asn-Ser, methionine, or cysteine, did anyone speak to how those residues behave over time?

The vial is not frozen in time. It is a small chemical system that keeps reacting at a rate set by its sequence and its storage. Reading documentation well means asking when the testing happened, under what storage, and which slow reactions the certificate does and does not address.

For lab records, the useful next step is to note each certificate's storage and stability documentation alongside the testing date, so the gap between test date and use date is visible instead of assumed away. For the material in front of you, ask for the batch documentation that covers storage and stability, not just the headline purity.

For research use only. Not for human or veterinary consumption.

Sources

Geiger, T., and Clarke, S. (1987). "Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides." Journal of Biological Chemistry. https://jbc.org/article/S0021-9258(19)75855-4/fulltext

Robinson, N. E., and Robinson, A. B. (2001). "Prediction of protein deamidation rates from primary and three-dimensional structure." Proceedings of the National Academy of Sciences. https://www.pnas.org/doi/10.1073/pnas.071066498

"Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems." Advanced Drug Delivery Reviews (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10526705/

Sigma-Aldrich. "Peptide Stability and Potential Degradation Pathways." Technical article. https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/research-and-disease-areas/cell-and-developmental-biology-research/peptide-stability